EquityFlow
›
Companies
› Normax Biomed
Normax Biomed
Biotech
· Cork, IE
mRNA vaccine R&D and manufacturing company
Funding history
Date
Round
Amount
Jun 2022
Incoming IPO
Normax Biomed, an Irish mRNA-vaccine company, raised €300M in pre-IPO capital ahead of a planned dual listing.
$300M
Similar companies in Biotech
Imperagen
Haga Bioscience
Pixelgen Technologies
Gallant
Chai Discovery
SNIPR Biome
Cellbox Labs
Scope Biosciences
GenLumina
Actithera
NUCLIDIUM
Anocca
Explore funding flow on EquityFlow →